Collegium Pharmaceutical (COLL) Other Operating Expenses (2016 - 2025)
Collegium Pharmaceutical's (COLL) quarterly Other Operating Expenses came in at -$19000.0 in Q4 2025, up 99.85% year-on-year from -$9507.3 in Q4 2024, and up 99.83% quarter-over-quarter from -$10.9 million in Q3 2025.
Collegium Pharmaceutical (COLL) Other Operating Expenses (2016 - 2025) Analysis & Trends
Collegium Pharmaceutical's Other Operating Expenses history runs 5 years deep, the most recent figure standing at -$19000.0 for Q4 2025.
- On a quarterly basis, Other Operating Expenses rose 99.85% year-over-year to -$19000.0 in Q4 2025; TTM through Mar 2026 was -$21.1 million, a 49.84% increase from a year earlier, with the FY2025 full-year figure at -$1.2 million, up 96.77% from the prior year.
- Other Operating Expenses improved to -$19000.0 in Q4 2025 per COLL's latest filing, from -$10.9 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at -$19000.0 in Q4 2025 and bottomed at -$14.1 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Collegium Pharmaceutical | 1.14 Bn | 853.50 Mn | 117.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -19,000.00 |
| Sep 30, 2025 | -10.92 Mn |
| Jun 30, 2025 | -10.16 Mn |
| Mar 31, 2025 | -14.08 Mn |
| Dec 31, 2024 | -12.39 Mn |
| Sep 30, 2024 | -7.80 Mn |
| Jun 30, 2024 | -7.81 Mn |
| Mar 31, 2024 | -8.62 Mn |
| Dec 31, 2018 | 29.73 Mn |
| Sep 30, 2018 | 46.01 Mn |
| Jun 30, 2018 | 46.84 Mn |
| Mar 31, 2018 | 43.11 Mn |
| Dec 31, 2017 | 1.09 Mn |
| Sep 30, 2017 | 553,000.00 |
| Jun 30, 2017 | 577,000.00 |
| Mar 31, 2017 | 371,000.00 |
| Dec 31, 2016 | 184,000.00 |
| Sep 30, 2016 | 29,000.00 |